SELLAS Life Sciences Group, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2012 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
SELLAS Life Sciences Group, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2012 to Q1 2022.
  • SELLAS Life Sciences Group, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending March 31, 2022 was $1M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $1M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-Q 2022-05-12
Q2 2015 $1.82M -$334K -15.5% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $1.06M -$406K -27.7% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $1.84M -$1.84M -50.1% Dec 31, 2014 10-Q 2015-08-06
Q3 2014 $1.44M -$108K -7% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $2.15M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $1.47M Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $3.68M +$3.68M Dec 31, 2013 10-K 2015-03-05
Q3 2013 $1.54M Sep 30, 2013 10-Q/A 2013-11-07
Q4 2012 $0 Dec 31, 2012 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.